Impact of Non-invasive Brain Stimulation on Learning Novel Spoken Words

April 25, 2024 updated by: C. Nikki Arrington, PhD, Georgia State University

Evaluating the Impact of Non-Invasive Brain Stimulation on Learning and Consolidation of Phonologically Similar Novel Spoken Words

The purpose of the proposed study is to use transcranial magnetic stimulation (TMS) to evaluate a neurobiological model of spoken word learning in older youth. Specifically, it is hypothesized that: (1) inhibition of the left dorsal stream will impact subsequent learning, processing, and retention of phonologically similar pseudowords; (2) the impact of dorsal stream inhibition on word learning will be associated with baseline levels of variability in neural activity, indicative of underlying differences in cortical excitability.

Study Overview

Detailed Description

The proposed study is designed to assess the contribution of the dorsal stream of the language network (i.e., left supramarginal gyrus, or SMG) to different aspects of novel word learning in two groups of participants (16-24 years of age): 20 typically developing older youth (OYTD; tested in Aim 1) and 20 older youth with reading difficulties (OYRD; tested in Aim 2). The investigators will use inhibitory continuous theta burst stimulation (cTBS), a well-established repetitive TMS (rTMS) protocol that reduces cortical excitability in a targeted brain region for up to 60 minutes. Participants will complete a baseline magnetic resonance imaging (MRI) session in Week 1, followed by cTBS or sham stimulation to the left SMG, with order of administration counterbalanced across participants. Immediately following cTBS (or sham), participants will complete a visual pseudoword phonological discrimination task and a spoken word learning task. The following day (i.e., 24 hours later), retention of items learned will be measured. In Week 2, cTBS (or sham) will be administered to the left SMG (whichever stimulation was not administered in Week 1) and then the pseudoword discrimination and word learning tasks will be administered using a different set of novel words from those presented in Week 1. Twenty-four hours later, the retention of this second set of items will be measured.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Georgia
      • Atlanta, Georgia, United States, 30318
        • Recruiting
        • Georgia State University/Georgia Tech Center for Advanced Brain Imaging (CABI)
        • Contact:
          • C.Nikki Arrington, PhD
          • Phone Number: 404-385-8621

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Native English speaker (who is not fluent in any other language and does not identify as bilingual)
  • Normal or corrected to normal vision

Exclusion Criteria:

  • Diagnosed with Autism Spectrum Disorder
  • Hearing deficits (>25 decibels at 500+ Hz), visual deficits (>20/40), serious emotional problems (e.g., severe, uncontrolled depression) and certain neurological conditions (e.g., uncontrolled seizure disorders)
  • Individuals with certain metals in their bodies or with certain health conditions. If an individual has braces on their teeth, a cardiac pacemaker; hearing aid; other metal in their body or eyes (which may include certain metallic-embedded tattoos), including but not limited to pins, screws, shrapnel, plates, dentures or other metal objects
  • Individuals taking certain medications that lower seizure threshold
  • Individuals with TMS Screening and Contraindication Forms which do not pass TMS Tech review
  • Individuals with MRI Screening and Contraindication Forms which do not pass MRI Tech review

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Active cTBS
Active cTBS will be administered to the left supramarginal gyrus
Active stimulation
Sham Comparator: Sham stimulation
Sham stimulation will be administered to the left supramarginal gyrus
Control stimulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Novel Word Learning Task
Time Frame: 5-mins post stimulation; 24hrs post stimulation
The spoken word learning task, completed post-cTBS, will consist of a two-alternative forced choice paradigm in which participants will be presented with two pictures of unusual objects, and will be asked to indicate via button press which picture matches a spoken label. Initial trials require a pure guess, with feedback provided on each trial, and continued until a correct answer is given. Across six learning blocks (24 trials each), participants will learn a set of eight pseudowords total. Twenty-four hours following the initial learning task, participants will be asked to complete two additional learning blocks which will be used to assess retention accuracy. Over the course of the experiment, participants will learn two different sets of items, counter-balanced across participants and groups.
5-mins post stimulation; 24hrs post stimulation
Pseudoword Discrimination Task
Time Frame: Immediately following cTBS
The visual pseudoword discrimination task is a computerized forced-choice, reaction time assessment of phonological processing. It measures the participants' ability to phonetically decode a string of letters. This task is simple with high accuracy and has proven highly sensitive to individual differences in phonological decoding skills. Participants are asked to judge via button press whether a visually presented letter string can be pronounced like a 'real word' or not.
Immediately following cTBS

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MRI Scan
Time Frame: baseline
Pre-rTMS MRI scans will consist of anatomical and functional sequences consistent with well-established protocols in the field designed to assess baseline properties and functioning of the reading and language network. The functional MRI (fMRI) Picture Identification task is simple with high accuracy and has proven highly sensitive to individual differences in reading skills. Participants are asked to indicate via button press whether a target stimulus (written or spoken word) matches a picture cue. The fMRI Fast Localizer task rapidly presents sets of four words that vary based on orthographic, phonological, or semantic properties. Anatomical scans are necessary for localizing brain regions targeted for cTBS.
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Estimated)

October 31, 2024

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

April 11, 2024

First Submitted That Met QC Criteria

April 25, 2024

First Posted (Actual)

April 29, 2024

Study Record Updates

Last Update Posted (Actual)

April 29, 2024

Last Update Submitted That Met QC Criteria

April 25, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The Open Science Framework (OSF) will be engaged to facilitate research integration in multiple aspects including collaboration among personnel, study design, data collection and analyses, and publication access. In addition, neuroimaging and behavioral data will be shared by depositing it in the Collaborative Informatics and Neuroimaging Suite (COINS), a platform hosted by Georgia State University/Georgia Institute of Technology/Emory University Center for Translational Research in Neuroimaging and Data Science (TReNDS). TReNDS allows for safe and secure data sharing with external users without granting access to protected health information. For preprints, platforms such as PsyArXiv and OSF Preprints will be used based on appropriate content area. All personnel will commit to use OSF to publicly share evaluation and research components.

IPD Sharing Time Frame

Timely submission of raw data to repositories will provide an additional layer of safety. Neuroimaging data will be uploaded to COINS in real time. Cleaned behavioral datasets will be uploaded to OSF biannually. Metadata, code, small datasets and links to large datasets used in publications will be archived as supplements or on OSF. Publication specific data will be deposited to the OpenNeuro platform upon publication. All shareable data from this project will be made publicly available no later than the end of the project period, and any data associated with a publication will be made available at the time of publication. The latest point at which data will be provided to the archive is when articles using that data are accepted for publication, or at the conclusion of the project (whichever comes first).

IPD Sharing Access Criteria

Any physical data for this project will be stored within locked filing cabinets for print copies and digital files will be encrypted and stored on password-protected secure servers separately from any participant code keys. Archived data will be stored on a secure server at Georgia State University when primary planned analyses of the data have been completed. The server will be backed up regularly using a tape backup system. The partition where data will sit on the server will not be accessible to anyone outside of the team.

Audit trails are maintained for each file to document changes and deletions, and older versions of files are retrievable in the event of unintentional modification.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dyslexia

Clinical Trials on Active cTBS

3
Subscribe